Cheminformatic Tools and Databases for Pharmacology

session 73481 - Total of 2 hits - Display   hits per page:

Add another drug(s) by one keyword:
Exemple: “nib“ and click on the Search button (do not press Enter on the keyboard)

1 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
M SELEXIPAG (is an active metabolite)

SELEXIPAG


ATC B01AC27

BLOOD
SELECTIVE NON-PROSTANOID IP PROSTACYCLIN RECEPTOR AGONIST
TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH)

-

Tmax 3.5 HOUR

PPB 99 PERCENT

HT 9.8 HOUR

IP PROSTACYCLIN RECEPTOR

GPCR PI2R_HUMAN AGONIST P43119ANSM (in French)

Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank

2 INNClassRoute (list)PK parameters= Cmax; Tmax; F: bioavailability; t1/2: half-life; VD: volume of distribution; Cl: clearance; PPB: plasma protein binding;(EQN means that value was calculated using VD=(Cl*t1/2)/0.693)Primary Target and PDB code of Protein-Drug complexTargets from DrugCentral Links
SELEXIPAG (has an active metabolite)

SELEXIPAG


ATC B01AC27

BLOOD
SELECTIVE NON-PROSTANOID IP PROSTACYCLIN RECEPTOR AGONIST
TREATMENT OF PULMONARY ARTERIAL HYPERTENSION (PAH)

ORAL

Tmax 2 HOUR

PPB 99 PERCENT

Cl 35 LITER / HOUR

HT 1.65 HOUR

SOLUBILITY PRACTICALLY INSOLUBLE IN WATER

IP PROSTACYCLIN RECEPTOR

GPCR PI2R_HUMAN AGONIST P43119ANSM (in French)

Dailymed
Drugs.com

SIDER side effects

Chemical Probes Portal

ChEMBL
BindingDB
DrugBank



Copyright © 2019 Université Côte d'Azur CNRS - All rights reserved
  | Contact |